Stock analysts at StockNews.com assumed coverage on shares of China Pharma (NYSE:CPHI – Get Free Report) in a report released on Saturday. The firm set a “hold” rating on the stock.
China Pharma Stock Performance
Shares of CPHI stock opened at $0.25 on Friday. China Pharma has a 12 month low of $0.17 and a 12 month high of $1.21. The company’s fifty day moving average price is $0.21 and its 200-day moving average price is $0.27. The company has a debt-to-equity ratio of 0.19, a quick ratio of 0.24 and a current ratio of 0.84.
China Pharma (NYSE:CPHI – Get Free Report) last released its earnings results on Wednesday, August 14th. The company reported ($0.09) earnings per share for the quarter. China Pharma had a negative net margin of 70.47% and a negative return on equity of 60.19%. The firm had revenue of $0.93 million for the quarter.
China Pharma Company Profile
China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.
Featured Stories
- Five stocks we like better than China Pharma
- What is a Bond Market Holiday? How to Invest and Trade
- The Outlook for Interest Rate Cuts Got Blown Out of the Water
- 3 Warren Buffett Stocks to Buy Now
- 3 High-Risk, High-Reward Micro-Cap Stocks You Shouldn’t Ignore
- CD Calculator: Certificate of Deposit Calculator
- 3 Bargain Stocks Positioned for Gains After Missing 2024’s Rally
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
